July 2026

Why Pharmacy and Clinical Liaisons Have Become Essential in Specialty Medicine

Here’s a question worth considering: Why can a specialist determine the right biologic therapy in ten minutes, while a patient may wait three weeks before receiving it?

The answer has little to do with the medicine itself and everything to do with what happens after the prescription is written. Benefit verification, step therapy requirements, specialty pharmacy coordination, and financial assistance paperwork all stand between a treatment decision and the patient who needs it. Someone has to navigate that process, and increasingly, that person is the pharmacy and clinical liaison.

Chris Podlin is one example of a pharmacy and clinical liaison who built expertise coordinating biologic therapies in dermatology before expanding his focus to gastroenterology. His career path illustrates how this role has become increasingly important in helping patients access specialty therapies.

What the Role Actually Involves

At its core, the job is about translation.

Every specialty prescription involves three distinct perspectives. Payers communicate through policy requirements and formulary guidelines. Providers focus on disease activity, treatment history, and clinical outcomes. Patients bring their own concerns, including symptoms, uncertainty, and financial considerations. The liaison connects these perspectives, ensuring important information moves between each group without losing context.

In practice, that means reviewing a denial letter and recognizing the specific clinical information a payer is looking for. It means identifying when a prescription that moves smoothly through one insurance plan may encounter step therapy requirements under another and addressing potential issues before they become delays. It also means helping patients feel comfortable with treatments like self-injections by explaining the process clearly and confidently.

No single degree program teaches the combination of immunology knowledge, insurance navigation, and patient communication this role requires. That expertise develops through experience, repetition, and firsthand understanding of the challenges patients face.

The position also depends heavily on relationships. A liaison who knows specialty pharmacy contacts, has established credibility with manufacturer field teams, and has earned the trust of providers can often resolve obstacles in hours instead of weeks. That network may not appear on an organizational chart, but it can become one of the most valuable resources a practice has.

Why Dermatology Became the Training Ground

Dermatology adopted biologic therapies earlier and more extensively than many other outpatient specialties. Psoriasis alone drove the development and adoption of multiple targeted therapies, each with its own screening requirements, dosing schedules, and payer considerations.

Coordinators working in this environment learned how to manage complex therapies at scale, and that experience created a strong foundation for handling advanced treatments across other specialties.

Managing hundreds of biologic patients requires consistency and structure. Tuberculosis screening must be completed before initiation. Laboratory monitoring needs to align with treatment schedules. Authorization documentation must be thorough enough to withstand payer review. Renewal calendars, appeal processes, and manufacturer assistance programs all need to function as reliable systems rather than last-minute solutions.

Patient education also became a critical part of the role. Because self-injection can feel intimidating, successful coordinators learned how to explain treatments in a way that builds confidence, encourages adherence, and helps patients stay engaged with their care.

Why Gastroenterology Is the Next Frontier

As specialty medicine continues to expand, inflammatory bowel disease has emerged as one of the next major areas for advanced therapies. Patients with Crohn’s disease and ulcerative colitis now have access to biologics and small molecule treatments that were not available just a decade ago, but each new therapy also brings additional payer requirements and access challenges.

The need for experienced liaisons in gastroenterology mirrors many of the challenges dermatology faced years earlier.

The overlap is significant. Several therapies are approved across both specialties, meaning a coordinator with dermatology experience already understands many of the medications, manufacturer support programs, and payer behaviors involved. The clinical focus may shift, requiring knowledge of therapeutic drug monitoring, infusion processes, and gastrointestinal disease documentation, but the foundation remains the same.

A liaison who applies proven access strategies while building specialty-specific knowledge can become productive quickly. The transition from dermatology to gastroenterology is less about changing careers and more about bringing tested expertise to a specialty where patients increasingly depend on timely access to advanced treatments.

The Access Challenges Patients Rarely See

When patients think about starting a biologic therapy, they often remember the waiting more than the science.

They remember the days between the specialist visit and the pharmacy call. They remember the uncertainty of wondering whether insurance would approve the treatment or whether cost would make continuing therapy unrealistic. Prior authorization remains one of the biggest challenges in specialty medicine, and successfully navigating that process requires experience, attention to detail, and a deep understanding of payer requirements.

Strong authorization submissions anticipate what reviewers need to see: documented treatment history, objective measures of disease severity, and a letter of medical necessity that connects clinical evidence directly to the payer’s own criteria.

Even with careful preparation, denials still happen. When they do, the process becomes more involved. Appeals require additional documentation, and peer-to-peer reviews require coordination between physicians and insurance medical directors, often while patients are waiting for answers.

At the same time, another challenge runs alongside the approval process: affordability. Copay assistance programs, foundation support, and manufacturer resources can make the difference between a patient starting therapy and abandoning treatment altogether.

Insights shared by professionals who fight these battles every day reveal a reality many patients never see: access isn’t simply a final administrative step after good medicine. It’s what determines whether patients can actually receive that medicine in the first place.

Why Experience Across Specialties Creates Greater Value

Specialists often build expertise through depth in one clinical area. Liaisons create value by applying experience across multiple specialties.

A coordinator who has worked with different therapeutic categories begins recognizing patterns that extend beyond a single disease state. They understand how payers evaluate documentation, anticipate common barriers, and identify workflow improvements that can benefit multiple areas of a practice.

The most effective liaisons also learn from challenges. Every denial, delay, and approval process provides insight into how systems operate and how future cases can be handled more effectively.

That experience benefits everyone involved. Nurses receive answers before coverage questions become obstacles. Providers gain a partner who anticipates challenges instead of simply reporting them after they occur. New team members inherit established processes rather than having to build them from scratch.

For specialty practices, this type of professional brings more than administrative support. They provide operational knowledge, clinical understanding, and the ability to help patients move from prescription to treatment with fewer barriers.

Specialty medicine will continue producing groundbreaking therapies, but those treatments only make a difference when patients can access them.